Portugal vs United States: Proportion of isolates with decreased susceptibility or resistance
Portugal
0
in 2018
United States
0.2907
in 2018
Portugal rank
15th
United States rank
14th
Proportion of isolates with decreased susceptibility or resistance over time
- Portugal
- United States
How they compare
United States currently reports 0.2907 against 0 in Portugal, a difference of 0.2907.
The two have swapped places 2 times across 10 shared years of data; in 2009 it was United States ahead.
Portugal ranks 15th and United States ranks 14th of 27 countries.
United States has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Portugal | United States | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 | 0.7993 | 0.7993 | United States |
| 2010s | 0.1543 | 0.3382 | 0.1839 | United States |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Portugal or United States?
- United States, at 0.2907 against 0 in Portugal as of 2018.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Portugal and United States?
- 0.2907, with United States ahead.
- How many years of comparable data are there for Portugal and United States?
- 10 years are reported by both, from 2009 to 2018.
- How do Portugal and United States rank globally for proportion of isolates with decreased susceptibility or resistance?
- Portugal ranks 15th and United States ranks 14th of 27 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.